Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no fixed minimum weight for Mounjaro. The licence for tirzepatide in the UK sets a BMI threshold, not a number on the scales: adults with a BMI of 30 or above qualify on BMI alone, and those with a BMI of 27 or above may qualify if they have at least one weight-related health condition. A prescriber reviews the full clinical picture before any treatment is approved — the BMI figure is the starting point, not the whole story. These are Prescription-Only Medicines that require a clinical assessment; a prescriber decides suitability for each individual.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
One of the most common misconceptions is that Mounjaro becomes available at a certain weight in kilograms, perhaps 100kg, or 80kg, or some other headline figure. This is not how the licensing works. The UK licence for tirzepatide, as set out by the MHRA and reflected in the NHS medicines information for tirzepatide, is built around BMI: a ratio of weight to height that accounts for body size rather than raw mass. Two people both weighing 85kg could have entirely different BMIs depending on their height, and entirely different eligibility outcomes as a result.
The practical consequence is that asking "what is the minimum weight for Mounjaro" leads you in the wrong direction. The right question is whether your BMI meets the threshold, and whether your overall health profile makes treatment appropriate. That second part matters. A prescriber considers factors like cardiovascular history, blood pressure, kidney function and current medications, things the scales cannot tell you.
If you want to work through the numbers before anything else, the NHS BMI calculator is a useful first step. It will give you a figure; what to do with that figure is a clinical conversation.
The licensed eligibility criteria for Mounjaro in the UK are straightforward on paper, though the detail matters. A BMI of 30 or above qualifies you on BMI alone, alongside a reduced-calorie diet and increased physical activity. A BMI of 27 to 29.9 can also qualify, provided you have at least one weight-related condition, common examples include high blood pressure, type 2 diabetes or prediabetes, high cholesterol, obstructive sleep apnoea, or osteoarthritis.
For people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, NICE guidance under TA1026 applies a threshold 2.5 kg/m² lower throughout, so BMI ≥27.5 instead of ≥30 as the primary threshold, for instance. A prescriber who knows your background will factor this in.
It is also worth understanding what the consultation is assessing beyond the BMI figure. There are conditions where tirzepatide is not appropriate: a personal or family history of certain thyroid cancers, previous pancreatitis, and some other gastrointestinal conditions are all factors your prescriber will ask about. You can read through the fuller detail of what this assessment covers on the Mounjaro weight eligibility page.
Treatment itself starts at 2.5mg, a dose whose job is to let your system adjust gradually, with titration managed by your prescriber from there.
A source of real confusion is that the NHS applies a stricter, phased set of criteria on top of the licensed thresholds, criteria that have nothing to do with the medicine's licence and everything to do with NHS resource allocation. Currently, NHS access to tirzepatide requires a BMI of 40 or above plus four or more of a defined list of weight-related conditions. That threshold is narrowing over time, but for most people the NHS route involves either not qualifying yet or a significant wait.
Private treatment through a regulated online pharmacy operates against the licensed criteria described above (BMI ≥30, or ≥27 with a qualifying condition) reviewed by a prescriber on the same basis a GP would use. If cost is part of what you are weighing up, the Mounjaro cost context page sets out what private pricing typically looks like and what a legitimate price should include.
For people whose BMI sits below the Mounjaro thresholds, or who are exploring all options before deciding, there are other licensed weight-management medicines available in the UK. The weight-loss treatment overview covers the broader picture without pushing any single route.
At nume, your consultation is read by a GPhC-registered Independent Prescriber (a real clinician, not software) on the same day you submit it. Identity is verified by photo ID, and live weight verification happens on a short video call, so the BMI calculation is based on an actual recorded measurement rather than a self-reported figure. This matters: it protects you, and it is one of the things that separates a clinically serious service from a checkbox exercise.
If you submit before noon on a working day and are approved as clinically suitable, your treatment is dispatched the same day and arrives with DPD the next working day in plain, unbranded packaging, no labels visible to whoever picks up the post. There is a lot of background reading available through our FAQs if you want to understand the process in more detail before starting, and our clinical team (including our prescribers) are reachable seven days a week for aftercare questions.
If you are still at the stage of comparing medicines, the tirzepatide and Mounjaro comparison page explains why those two names refer to the same medicine, while the alternatives to Mounjaro page covers what else is licensed for weight management in the UK if Mounjaro turns out not to be the right fit after your assessment. If you are unsure whether your current weight meets the criteria, our guide on what weight you have to be for Mounjaro walks through the thresholds in plain terms, and a related page covering what weight you need to be for Mounjaro explains how those figures apply to your individual circumstances.
When you are ready, start your free consultation and a prescriber will review your details the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.